SOLUTIONS

Solution

PDTZSY

Release time:

2020-12-28 16:29

Source:

PDTZSY employs a randomized, double-blind, placebo-controlled, multicenter clinical trial design.
This product is an immunomodulatory drug that exerts a bidirectional regulatory effect on the body’s immune functions, promoting T-cell maturation and enhancing lymphocyte immune function. It is clinically intended for use in combination with chemotherapy for the treatment of non-small cell lung cancer.

Recommended Services

Early clinical development

Early clinical development

2020-09-25

Eurasia Huizhi boasts more than ten Phase I strategic collaboration centers, providing high-quality, specialized resources for early-phase clinical studies of innovative drugs. For each project, our expert medical team drafts initial clinical study protocols, consults with clinical experts in relevant fields, and develops clinically feasible and regulatory-compliant implementation plans. The company has extensive experience in conducting clinical trials for a variety of new drugs, including chemical drugs, traditional Chinese medicines, and biologics. Our services include: 1) Feasibility Assessment: Clinical trial feasibility evaluation, identification of centers/researchers, and center feasibility assessment & qualification review. 2) Medical and Clinical Strategy & Planning: Clinical trial planning & execution, risk identification & management.

Generic Drug Clinical Studies

Generic Drug Clinical Studies

2020-09-25

Opinions of the General Office of the State Council on Conducting Evaluations of the Quality and Efficacy Consistency of Generic Drugs (Guobanfa [2016] No. 8) Generic drugs that were approved for marketing prior to the implementation of the new classification system for chemical drug registration—and which have not been approved in accordance with the principle of consistency in quality and efficacy with the originator drugs—must undergo consistency evaluations. The consistency evaluation of generic drugs refers to the phased and batch-wise assessment of the quality consistency of generic drugs already approved for marketing, based on the principle of consistency in quality and efficacy with the originator drugs. In other words, generic drugs must achieve a level of quality and efficacy that is consistent with the originator drugs. The purpose of conducting these consistency evaluations is to ensure that generic drugs are comparable to the originator drugs in terms of both quality and efficacy.

Post-Marketing Reevaluation Study

Post-Marketing Reevaluation Study

2020-09-25

Phase II-IV Clinical Study

Phase II-IV Clinical Study

2020-09-25

Personnel Outsourcing (FSP) Services

Quality Assurance Services

Quality Assurance Services

2020-09-25

Registration Affairs

Registration Affairs

2020-09-25

Leave a message for inquiry

Submit a message